A Study to Assess the Safety & Drug Levels of BMS-986256 in Participants

Updated 06/21/2024

Status Completed

Clinical Trial Summary

The purpose of this study is to assess the safety and drug levels of BMS-986256 in participants with cutaneous lupus erythematosus.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04493541
Study type	Interventional
Source	Bristol-Myers Squibb
Contact
Status	Completed
Phase	Phase 1
Start date	August 26, 2020
Completion date	April 21, 2023

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02034344` - A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers	Phase 0
	Terminated	`NCT01559155` - Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid
	Completed	`NCT01702740` - A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus	Phase 1
	Withdrawn	`NCT00222183` - Cutaneous Lupus Erythematosus and Elidel	N/A
	Withdrawn	`NCT04707924` - Efficacy of Fractional Er:YAG Laser in Lupus Erythematosus Scars	N/A
	Recruiting	`NCT05879718` - A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.	Phase 2
	Completed	`NCT01352988` - Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus	Phase 2
	Enrolling by invitation	`NCT00420121` - European Society of Cutaneous Lupus Erythematosus (EUSCLE)	N/A
	Completed	`NCT01845740` - Phase Ib Study of SC Milatuzumab in SLE	Phase 1
	Completed	`NCT02927457` - Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects	Phase 1
	Completed	`NCT02656082` - Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus	Phase 2
	Terminated	`NCT02428309` - Autologous Polyclonal Tregs for Lupus	Phase 1
	Terminated	`NCT01407679` - Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus	Phase 2
	Completed	`NCT01923415` - A Non-drug Study Profiling Cutaneous Lupus	Phase 0